Skip to main content Skip to footer
ETCapital  logo
  • About
  • CVI Fund
  • Funds Managed
  • Portfolio
  • Investors
  • News
  • Contact

April 2025

Democratising the Future of Venture Capital with ET Captial.

March 2025

ET Capital launches new fund offering tax efficient access to a diversified range of Cambridge start-ups for individual investors.

August 2023

Carbon Engineering has been acquired by Occidental Petroleum (NYSE: OXY) in a $1.1B all cash transaction.

September 2022

Bango (AIM:BGO) announced the acquisition of Docomo Digital - the global payments business of NTT DOCOMO - bringing an additional $3.5B of end user spend from c.2 billion users worldwide.

April 2021

Phico Therapeutics awarded up to $18.2 million (c.£13.2 million) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials.

April 2021

FDA approves first ADC Therapeutics anti-cancer drug, ZYNLONTA™, for clinical use in patients with relapsed or refractory diffuse large B-Cell Lymphoma.

We receive many investment enquiries each month but please email info@etcapital.com to find out more.

ET Capital Limited © 2025
Company registration no: 02282335. Registered in England. and Wales at Registered address: 15a Water Lane, Impington, Cambridge, CB24 9XW
Authorised and regulated by the Financial Conduct Authority (FRN 148594)
Legal & Privacy
Website by 2idesign ltd // Creative Agency // Cambridge